Westminster Health Forum

Since lockdown, we have been organising our full programme of conferences online. We will continue online until further notice, to ensure we play our part in helping our employees and delegates to remain safe during this time. We are pleased that so many key stakeholders, policymakers and other interested parties - both old friends and new delegates - are taking up the opportunity to discuss public policy issues and network at our impartial seminars. New events are coming on to our conference programme all the time. So there are plenty of opportunities for you to join us if you haven’t already, from wherever you are. For booking-related queries, or information on speaking, please email us at info@forumsupport.co.uk or contact us using one of the following numbers: +44 (0)7951044809 / +44 (0)7503591880 / +44 (0)7538736244.
For delegates already booked on, we will send you the online joining instructions (including links, event numbers and passwords) five working days before your conference. If you cannot find these in your inbox please email delegate.relations@forumsupport.co.uk

Priorities for improving patient safety in the NHS - strategy and regulation, learning and innovation, and responding to COVID-19

Morning, Wednesday, 21st October 2020

Online Conference


***Full-scale policy conference taking place online***

This conference will discuss the priorities for ensuring patient safety in the NHS - including in relation to the response to the COVID-19 pandemic.


Areas for discussion include:

  • the impact of the publication of the Independent Medicines and Medical Devices Safety Review report First Do No Harm, as the Government commits to responding in full, and with initial comments in parliament from the Minister of State for Patient Safety
  • progress on implementation of the first NHS Patient Safety Strategy released last year - and the impact of the pandemic on its delivery
  • latest thinking and next steps on learning from harm, engaging with patients and families, and developing a learning culture in the NHS

Sessions also assess the response to COVID-19, maintaining patient and workforce safety during the crisis, tailoring approaches for at risk groups, and adapting care delivery practices.


We are pleased to be able to include in the agenda keynote sessions with: Nigel Acheson, Deputy Chief Inspector of Hospitals, CQC; Keith Conradi, Chief Investigator, Healthcare Safety Investigation Branch; Dr Sonia MacLeod, Researcher, Independent Medicines and Medical Devices Safety Review; Paula McLaren, National Clinical Lead for Quality & Patient Safety, Health Education England; Marie Moore, Transformation and Patient Safety Lead, Health Education England; and Natasha Swinscoe, Chief Executive Officer, West of England AHSN and National Lead for Patient Safety, AHSN Network - as well as contributions from Phil Brown, Director, Regulatory and Compliance, ABHI and John Machin, Clinical Lead, Litigation, GIRFT.


The discussion in detail:

Policy and its implementation

  • The Patient Safety Strategy and key issues for delivering safe care in the NHS, looking at:
    • reducing unwarranted variation in patient safety
    • attracting clinicians into high risk specialties
    • the role of technology and utilising data to reduce and prevent errors
    • implementing the strategy in local health systems
  • Findings from the review into the response to patient treatment concerns and what can be learnt going forward

Developments in clinical practice and operational procedures

  • Maintaining patient safety for COVID-19 patients and the workforce - including discussion on:
    • its impact on service delivery, continuity of care and non-urgent care
    • what is being done to tailor services to those in at-risk groups, including those with underlying health conditions and BAME groups
  • The development of a new Patient Safety Incident Response Framework, and findings from the early adopters scheme, working with providers on the appropriate response to patient safety incidents and investigations which will then improve insight for learning going forward

Innovation and training

  • The development of the national patient safety syllabus to ensure the workforce receives effective education, skills and training in patient safety as part of the new strategy, as well as the importance of addressing workforce challenges, wellbeing and support for delivering care
  • How local patient safety data can be analysed to create improved learning and practice, and ways the new system can encourage the reporting of incidents and achieve a learning and not a blaming culture in the NHS

Regulation and oversight

  • The role of regulation in improving patient safety and reducing avoidable harm
  • Identification and investigation of factors leading to harm and the recommendations made as a result in improving safety and risk reduction
  • Priorities for the Healthcare Safety Investigations Branch
  • The impact of COVID-19 on investigations and any lessons it has provided for the future

Why this is relevant for discussion now - the context:

Key reports

  • publication of the Independent Medicines and Medical Devices Safety Review’s report First Do No Harm which makes wide-ranging recommendations, including:
    • appointment of an independent Patient Safety Commissioner
    • establishment of a Redress Agency to support those who have been harmed by medicines and medical devices
    • strengthening the MHRA’s engagement with and focus on patients
    • overhauling medical device regulation and adverse event reporting, and the establishment of a central medical device database
    • expansion of the General Medical Council register to include a list of financial interests for all doctors
  • findings in NHS Resolution’s Annual Report and Accounts that the cost of claims is rising although the number of claims is remaining steady

COVID-19


Further policy developments

  • the vision in the NHS Patient Safety Strategy for continuously improving patient safety, with an amended timescale for the development of some of its new programmes due to COVID-19
  • the opportunity for the NHS People Plan, expected later this year, to improve patient safety as it addresses workforce challenges, wellbeing and support for delivering care
  • a new Patient Safety Incident Management System in the NHS Long Term Plan, also looking at how local patient safety data can be analysed to create improved learning and practice
  • the Health Service Safety Investigations (HSSIB) Bill due to be reintroduced later this Parliamentary session, which would establish the HSSIB as a non-departmental public body to investigate patient safety incidents and make recommendations to prevent future safety failures

The agenda:

  • Progress of improving patient safety in the NHS
  • Maintaining patient safety during COVID-19 - rapid learning to respond to the virus, continuity of care, and adapting care delivery practices
  • Delivering safe care in the NHS - preventing errors, utilising data and technology, supporting the workforce, and promoting high quality leadership
    • Improving engagement with patients, families and the wider public
    • How to improve patient safety by reducing unwarranted variation and learning from clinical negligence claims
    • The role of technology in reducing errors, enhancing care, and ensuring safety in remote healthcare and telemedicine
    • Implementing the NHS Patient Safety Strategy locally - leadership, utilising data, and system learning
  • Next steps for developing and implementing a patient safety learning culture in the NHS
  • Taking forward the National Patient Safety Syllabus and supporting the workforce to deliver care safely during the presence of COVID-19
  • The role of the regulator in reducing avoidable harm and informing future practice
  • Learning from harm, reducing the cost of litigation in the NHS, and the impact of COVID-19
  • Assessing findings from the Independent Medicines and Medical Devices Safety Review
  • The impact of investigations in the NHS and the priorities of the Healthcare Safety Investigation Branch

Policy officials attending:

Our forums are known for attracting strong interest from policymakers and stakeholders.


This conference looks no different. Places have been reserved by representatives from the Department of Health and Social Care; NHS England and NHS Improvement; the Government Legal Service and the Welsh Government. Also due to attend are representatives from.


This is a full-scale conference taking place online***

  • full, four-hour programme including comfort breaks - you’ll also get a full recording to refer back to
  • information-rich discussion involving key policymakers and stakeholders
  • conference materials provided in advance, including speaker biographies
  • speakers presenting via webcam, accompanied by slides if they wish, using the Cisco WebEx professional online conference platform (easy for delegates - we’ll provide full details)
  • opportunities for live delegate questions and comments with all speakers
  • a recording of the addresses, all slides cleared by speakers, and further materials, is made available to all delegates afterwards as a permanent record of the proceedings
  • delegates are able to add their own written comments and articles following the conference, to be distributed to all attendees and more widely
  • networking too - there will be opportunities for delegates to e-meet and interact - we’ll tell you how!

Full information and guidance on how to take part will be sent to delegates before the conference



Keynote Speaker

Nigel Acheson

Deputy Chief Inspector of Hospitals, CQC

Keynote Speakers

Paula McLaren

National Clinical Lead for Quality & Patient Safety, Health Education England

Marie Moore

Transformation and Patient Safety Lead, Health Education England

Dr Sonia MacLeod

Researcher, Independent Medicines and Medical Devices Safety Review

Natasha Swinscoe

Chief Executive Officer, West of England AHSN and National Lead for Patient Safety, AHSN Network

Nigel Acheson

Deputy Chief Inspector of Hospitals, CQC

Keith Conradi

Chief Investigator, Healthcare Safety Investigation Branch

Speakers

John Machin

Clinical Lead, Litigation, GIRFT, NHS England and Improvement and The Royal National Orthopaedic Hospital and Clinical Fellow, Joint Reconstruction & Oncology, Department of Orthopaedics, University of British Columbia

Phil Brown

Director, Regulatory and Compliance, ABHI